Packaging & Device Strategies for Biosimilars: Navigating Regulatory, Legal, and Financial Hurdles

As the global market for biosimilars and novel therapeutics accelerates, developers face critical macro-strategic choices regarding primary packaging configuration and drug delivery device selection. This presentation examines the commercial execution realities of biosimilar packaging design. We will dissect the strict regulatory burdens of device compliance, the legal and intellectual property challenges of navigating device patent thickets, and the financial investment models required to scale production lines for global market access.

Key Topics Addressed:

Regulatory Gateways for Devices: Navigating shifting FDA, EMA, and emerging market compliance frameworks for combination products, pre-filled syringes, and primary packaging variations.

The Patent & Legal Landscape: Analyzing freedom-to-operate strategies and intellectual property risks associated with drug delivery device design and automated packaging layouts.

Financing & Commercial Scalability: Evaluating the capital expenditure and investment calculus behind establishing specialized, high-yield packaging networks across secondary economies